Chandragouda R. Patil

Shirpur, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Journal: Personalized medicine

Published: May 30, 2026

Quinazoline-based fourth-generation EGFR tyrosine kinase inhibitors to overcome C797S-mediated resistance in non-small cell lung Cancer (NSCLC).

Quinazoline-based fourth-generation EGFR tyrosine kinase inhibitors to overcome C797S-mediated resistance in non-small cell lung Cancer (NSCLC).

Journal: Bioorganic chemistry

Published: July 23, 2025

Antifibrotic Efficacy of Daclatasvir Against Pulmonary Fibrosis: Insights From Network Pharmacology, Molecular Docking, Dynamics, and Preclinical Evaluations.

Antifibrotic Efficacy of Daclatasvir Against Pulmonary Fibrosis: Insights From Network Pharmacology, Molecular Docking, Dynamics, and Preclinical Evaluations.

Journal: Chemistry & biodiversity

Published: June 27, 2025

Exploring the role of adipocytokines in obesity associated depression.

Exploring the role of adipocytokines in obesity associated depression.

Journal: Drug discovery today

Published: June 15, 2025

Repurposing clonixin and flunixin as anti-fibrotic candidates: Computational and preclinical evaluation in bleomycin-induced pulmonary fibrosis in rats.

Repurposing clonixin and flunixin as anti-fibrotic candidates: Computational and preclinical evaluation in bleomycin-induced pulmonary fibrosis in rats.

Journal: Research in veterinary science

Published: May 16, 2025

L-Borneol ameliorates renal fibrosis induced by unilateral ureteral obstruction in rats.

L-Borneol ameliorates renal fibrosis induced by unilateral ureteral obstruction in rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 29, 2025

In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis.

In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis.

Journal: Therapeutic delivery

Published: March 24, 2025

Comparative Efficacy of β-Carotene and Losartan Against Isoproterenol-Induced Cardiac Fibrosis: An Experimental and Computational Studies.

Comparative Efficacy of β-Carotene and Losartan Against Isoproterenol-Induced Cardiac Fibrosis: An Experimental and Computational Studies.

Journal: Journal of the American Nutrition Association

Published: February 10, 2025

A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

Journal: Bioorganic & medicinal chemistry

Published: January 16, 2025

Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches.

Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches.

Journal: Frontiers in pharmacology

Published: August 14, 2024

Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents.

Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents.

Journal: Journal of biomolecular structure & dynamics

Published: March 04, 2024

Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis: A Review.

Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis: A Review.

Journal: Current pharmaceutical biotechnology

Published: July 02, 2022

Showing 1-12 of 70

Last Updated: 09/26/2026